Yigal Nochomovitz
Stock Analyst at Citi
(4.70)
# 758
Out of 4,592 analysts
754
Total ratings
46.6%
Success rate
13.5%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Reiterated: Buy | $246 → $249 | $166.80 | +49.28% | 11 | Jul 31, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $40 | $13.02 | +207.22% | 19 | Jul 24, 2026 | |
| RCUS Arcus Biosciences | Maintained: Buy | $45 | $28.19 | +59.63% | 30 | Jul 22, 2026 | |
| LGND Ligand Pharmaceuticals | Initiated Coverage: Buy | $282 → $387 | $287.54 | +34.59% | 4 | Jul 21, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Sell | $13 | $14.86 | -12.52% | 13 | Jul 20, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $57 | $19.05 | +199.21% | 17 | Jul 14, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $35 → $37 | $21.94 | +68.64% | 32 | Jun 30, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $26 | $10.01 | +159.74% | 9 | Jun 30, 2026 | |
| ACAD ACADIA Pharmaceuticals | Rated: Buy | $32 → $35 | $25.87 | +35.29% | 7 | Jun 26, 2026 | |
| TVTX Travere Therapeutics | Rated: Buy | $62 → $70 | $55.89 | +25.25% | 18 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $105.95 | +36.86% | 2 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $405 → $453 | $316.01 | +43.35% | 7 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.17 | +498.29% | 19 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.46 | +447.95% | 22 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $18 | $7.07 | +154.60% | 13 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $20.46 | +71.07% | 3 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $8.06 | +73.70% | 6 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $29.82 | +44.20% | 13 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $11.45 | +441.48% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $10.37 | +102.51% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $69 → $81 | $36.81 | +120.05% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $5.30 | +277.36% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $31.44 | +30.41% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 → $3.1 | $2.31 | +34.20% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $44 | $18.27 | +140.83% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $82 | $47.99 | +70.87% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $24.91 | +80.65% | 29 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $378 | $341.12 | +10.81% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $11.07 | +44.53% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $24 | $8.03 | +198.88% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $35.50 | +83.10% | 19 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $11.79 | -23.66% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $12.25 | +185.71% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $22.53 | +86.42% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8 | $5.76 | +38.89% | 20 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $14 | $4.95 | +182.83% | 24 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.54 | +549.35% | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.72 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $11 | $2.75 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.41 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $0.026 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $3.69 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 → $1.2 | $2.22 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.45 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.54 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $10 | $8.38 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $8 | $1.75 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.44 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.4 → $0.25 | $15.62 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $68.01 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2 | $1.32 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €1.53 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $54.81 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $7.93 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.20 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $1.32 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.000001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.80 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $2.09 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $8.17 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $1.92 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.99 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.01 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,227.00 | n/a | 3 | Nov 21, 2014 |
Neurocrine Biosciences
Jul 31, 2026
Reiterated: Buy
Price Target: $246 → $249
Current: $166.80
Upside: +49.28%
Summit Therapeutics
Jul 24, 2026
Reiterated: Buy
Price Target: $40
Current: $13.02
Upside: +207.22%
Arcus Biosciences
Jul 22, 2026
Maintained: Buy
Price Target: $45
Current: $28.19
Upside: +59.63%
Ligand Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $282 → $387
Current: $287.54
Upside: +34.59%
Sarepta Therapeutics
Jul 20, 2026
Maintained: Sell
Price Target: $13
Current: $14.86
Upside: -12.52%
Syndax Pharmaceuticals
Jul 14, 2026
Maintained: Buy
Price Target: $57
Current: $19.05
Upside: +199.21%
Zymeworks
Jun 30, 2026
Maintained: Buy
Price Target: $35 → $37
Current: $21.94
Upside: +68.64%
Candel Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $26
Current: $10.01
Upside: +159.74%
ACADIA Pharmaceuticals
Jun 26, 2026
Rated: Buy
Price Target: $32 → $35
Current: $25.87
Upside: +35.29%
Travere Therapeutics
Jun 14, 2026
Rated: Buy
Price Target: $62 → $70
Current: $55.89
Upside: +25.25%
Jun 14, 2026
Maintained: Buy
Price Target: $145
Current: $105.95
Upside: +36.86%
Jun 12, 2026
Maintained: Buy
Price Target: $405 → $453
Current: $316.01
Upside: +43.35%
Jun 11, 2026
Maintained: Buy
Price Target: $7
Current: $1.17
Upside: +498.29%
Jun 11, 2026
Maintained: Buy
Price Target: $8
Current: $1.46
Upside: +447.95%
Jun 9, 2026
Rated: Buy
Price Target: $7 → $18
Current: $7.07
Upside: +154.60%
Jun 8, 2026
Rated: Buy
Price Target: $35
Current: $20.46
Upside: +71.07%
Jun 4, 2026
Rated: Buy
Price Target: $14
Current: $8.06
Upside: +73.70%
Jun 3, 2026
Maintained: Buy
Price Target: $43
Current: $29.82
Upside: +44.20%
May 31, 2026
Maintained: Buy
Price Target: $62
Current: $11.45
Upside: +441.48%
May 18, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $10.37
Upside: +102.51%
May 13, 2026
Rated: Buy
Price Target: $69 → $81
Current: $36.81
Upside: +120.05%
May 13, 2026
Rated: Buy
Price Target: $26 → $20
Current: $5.30
Upside: +277.36%
May 13, 2026
Reiterated: Buy
Price Target: $41
Current: $31.44
Upside: +30.41%
May 11, 2026
Maintained: Buy
Price Target: $2.3 → $3.1
Current: $2.31
Upside: +34.20%
May 8, 2026
Maintained: Buy
Price Target: $47 → $44
Current: $18.27
Upside: +140.83%
May 6, 2026
Rated: Buy
Price Target: $80 → $82
Current: $47.99
Upside: +70.87%
May 5, 2026
Maintained: Buy
Price Target: $45
Current: $24.91
Upside: +80.65%
May 5, 2026
Rated: Buy
Price Target: $371 → $378
Current: $341.12
Upside: +10.81%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $11.07
Upside: +44.53%
May 1, 2026
Rated: Buy
Price Target: $21 → $24
Current: $8.03
Upside: +198.88%
Apr 13, 2026
Maintained: Buy
Price Target: $65
Current: $35.50
Upside: +83.10%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $11.79
Upside: -23.66%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $12.25
Upside: +185.71%
Mar 9, 2026
Maintained: Buy
Price Target: $42
Current: $22.53
Upside: +86.42%
Mar 4, 2026
Rated: Hold
Price Target: $7 → $8
Current: $5.76
Upside: +38.89%
Jan 8, 2026
Maintained: Buy
Price Target: $11 → $14
Current: $4.95
Upside: +182.83%
Sep 3, 2025
Maintained: Buy
Price Target: $10
Current: $1.54
Upside: +549.35%
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.72
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $16 → $11
Current: $2.75
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.41
Upside: n/a
Sep 12, 2024
Maintained: Buy
Price Target: $12 → $10
Current: $0.026
Upside: n/a
Aug 15, 2024
Maintained: Buy
Price Target: $16 → $14
Current: $3.69
Upside: n/a
Jun 17, 2024
Maintained: Hold
Price Target: $3.5 → $1.2
Current: $2.22
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $10
Current: $2.45
Upside: n/a
Dec 4, 2023
Maintained: Buy
Price Target: $8
Current: $1.54
Upside: n/a
Nov 22, 2023
Maintained: Sell
Price Target: $35 → $10
Current: $8.38
Upside: n/a
Sep 18, 2023
Maintained: Buy
Price Target: $12 → $8
Current: $1.75
Upside: n/a
Sep 18, 2023
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.44
Upside: n/a
Aug 29, 2023
Maintained: Hold
Price Target: $0.4 → $0.25
Current: $15.62
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $68.01
Upside: n/a
Nov 28, 2022
Maintained: Buy
Price Target: $5 → $2
Current: $1.32
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: €12.00
Current: €1.53
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $54.81
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $7.93
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.20
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $1.32
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $5.80
Upside: n/a
Mar 31, 2015
Maintained: Buy
Price Target: $32
Current: $2.09
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $8.17
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $1.92
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $0.99
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $10.01
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,227.00
Upside: n/a